SMN1 and proximal spinal muscular atrophy: This is the first report in which SMN2 copy number, and transcript and protein measures of SMN expression in blood using the quantitative assay methodologies that reflect the current consensus in the field, have been applied prospectively to a large and broad cohort of subjects with SMA.